Dossier Requirements for the Drug Substance – An Introduction
- Chemical pharmaceutical documentation for active substance(s) – Regulatory requirements in EU and USA
- Types of active substances – types of documentation
- CTD Module 3, CEP and ASMF
- CEP for a substance for TSE risk assessment
Requirements for the Certificate of Suitability to the European Pharmacopoeia
- CEP Procedure: legal framework, the role, place and scope
- How the CEP procedure works for new CEPs
- Basic principles for maintaining the CEP: administrative, minor and major changes, renewal of CEPs
- Key figures and how to communicate with EDQM
The European Active Substance Master File Procedure
- Regulatory background and scope
- The revised European ASMF Guideline
- Applicant‘s and restricted parts - points to consider
- Questions & answers on the ASMF procedure
- Recent European developments: Sharing of assessment reports, data bases ….
Pharmaceutical Impurities: Residual solvents, synthesis-derived and mutagenic and elemental impurities
- CPMP-/ICH-Guidelines on Impurities and Residual Solvents
- ICH M7 Guideline on genotoxic impurities
- ICH Q3D(R1) Guideline on elemental impurities
- Specifying impurities
- Classifying solvents, setting and proving limits
- Justification of specification
Stability Data
- CPMP/ICH Guidelines
- Stability Summary and Conclusions, stability commitment
- Documentation of Stability Data
- Necessity for documentation of raw data?
How to read and use a CEP / Implementation of CEP 2.0
- How to interpret information laid down on CEP-practical examples
- Project CEP 2.0: What has changed and what are the benefits?
- CEP holders’ responsibilities towards their customers
- How to use a CEP in marketing authorization application
API Regulatory Starting Materials
- Why is this such a hot Topic
- What guidelines to consider
- How to define a suitable starting material
- How to defend your choice in the Submission
- What is different for generics
- Consequences of a redefinition
Top ten Deficiencies in new Applications for Certificates of Suitability for chemical Purity
- CEP process overview with focus on technical validation at reception
- How to build up a successful dossier and avoid deficiencies
- Top 10 most frequent question raised after the initial assessment of new applications for CEP with practical examples
- Expectations and recommendations on how to address the specific deficiencies with reference to applicable Guidelines
Comparison of the CEP and DMF Procedure
- Advantages of the CEP procedure
- Handling changes
- In which countries is the CEP being accepted?
- Cost Considerations
- Practical examples
Regulatory Procedures in the US and Japan
- Overview of the procedures
- Specifics for US and Japan
The EDQM Inspection Programme
- How does the EDQM inspection procedure work
- EDQM GMP Assessment tools: On-site inspections, documentation-based GMP Assessment and Real Time Remote Inspections (RTEMIS)
- Inspection facts and figures
Stability Studies and Establishing the Retest Date
Cristina Jimenez Sala
Description of the Manufacturing Process
Dr Wilhelm Schlumbohm
Important: In order to prepare the lectures and the workshops in an optimal way, please send your questions to special topics to Ms Anne Günster, guenster@concept-heidelberg.de. She will forward your questions to the responsible speaker. Thank you in advance for your cooperation.
Country specific Requirements
- General remarks on API registrations in Emerging Countries
- Details of API registration in:
- Taiwan
- India
- CIS countries: Russia, Belarus, Ukraine
- GCC countries - APIC Emerging Countries Interest Group
Regulatory Procedures in Brazil and China
- Overview of the procedures
- Specifics for Brazil and China
- Experiences
Variations/Changes and Life Cycle Management
- Types and categories of API changes
- EU: the variation regulation and CEP revisions
- Handling API changes in the US
- Handling API changes in Japan
- Handling API changes outside these regions
- Initiatives to facilitate changes